logo
  

Hyundai Motor Targets To Achieve Carbon Neutrality By 2045 - Quick Facts

At IAA Mobility 2021, Hyundai Motor (HYMLF.OB,HYMTF.OB) stated that it is committed to become carbon neutral in its global products and operations by 2045. The company will make investments in cleaner transportation and greener energy solutions to achieve the goal. Hyundai Motor also aims to meet the electricity needs of over 90 percent of its global operations with renewable energy by 2040.

By 2030, Hyundai plans to secure 30 percent of its global vehicles sales with ZEVs, and by 2040, expects that battery electric vehicles and Fuel Cell Electric Vehicles will account for 80 percent of its total fleet sales. By region, the company targets to offer only ZEVs in Europe, starting in 2035. By 2040, Hyundai will phase out all vehicles using fossil fuels in major markets.

At the International Motor Show Germany or IAA Mobility, Hyundai Motor is exhibiting BEV concepts, all-electric robotaxi model, and artistic displays on hydrogen value chain—in Hall A1, Messe Munich.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U. S. Food and Drug Administration or FDA has issued a public health alert against Fulvic Care Powder and Tablets from Ontario, Canada -based Black Oxygen Organics due to elevated levels of lead and arsenic. The agency advised consumers not to use Fulvic Care Powder and Tablets from Black Oxygen or give the products to pets due to elevated levels of lead and arsenic. Alexander & Hornung, a business unit of Perdue Premium Meat Co., Inc., is recalling around 234,391 pounds of fully cooked pork products citing possible contamination with Listeria monocytogenes, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced. The recall involves ham and pepperoni products that come under various brands and produced on various dates. Sandoz, Inc., an unit of Novartis AG, is recalling one lot of deep vein thrombosis (DVT) medication Enoxaparin Sodium in the form of injection for the potential exposure to high temperatures that may have impacted product effectiveness, the U.S. Food and Drug Administration or FDA said in a statement.
Follow RTT